What Happened?
San Diego, CA-based TrovaGene has appointed Charlie Rodi as Chief Technology Officer.
About the Company
TrovaGene is a molecular diagnostics company providing precise, noninvasive urine and blood testing for detecting and monitoring oncogene mutations. By utilizing proprietary technology that analyzes circulating tumor DNA, TrovaGene testing offers critical data that may help inform cancer treatment decisions, giving physicians and patients monitoring options beyond biopsy or imaging.
About the Person
Charlie Rodi was previously the Director of the Monsanto Genome Sequencing Center.
Info Source
News
Short Profile